CXCL10 and autosomal dominant cerebellar ataxia: IL-10's role as a biomarker in SCA is still controversial, since some authors describe lower levels in StSt, when compared to the control group, together with CXCL10 (43), while others found increased levels (20, 30, 46, 47) and some show no difference (17).